Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03304184 · ClinicalTrials.gov registry record · Phase 3
The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life
A Phase 3 study, sponsored by University of Michigan.
- Terminated
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT03304184: Clinical Trial Phase 3 study, sponsored by University of Michigan.
NCT03304184 is a Phase 3 study that was terminated before completion, run by University of Michigan. The registered enrollment target is 24 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03304184, a Phase 3 study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life.
Primary Outcome
A one survey description detailing the changes in pain over time based on the following scale: 1. -No change (or condition has gotten worse) 2. -Almost the same, hardly any change at all 3. -A little better, but no noticeable change 4. -Somewhat better, but the change has not made any real difference 5. -Moderately better, and a slight but noticeable change 6. -Better and a definite improvement that has made a real and worthwhile difference 7. -A great deal better and a considerable improvement
Interventions
- DEVICE Biodentine
- DEVICE Photac-fil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2019-10-09 |
| Phase | Phase 3 |
Why NCT03304184 stopped before completion
NCT03304184 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Biodentine is the first listed.
NCT03304184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03304184 about?
NCT03304184 is a clinical study titled "The Role of Biodentine in Class V Dental Lesions on Oral Health Related Quality of Life". The study will compare two different dental materials on dental lesions near the gum line that cause chronic pain on oral health related quality of life.
What is the current status of trial NCT03304184?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2017-09-28. Estimated completion is 2019-10-09.
What interventions are being tested in trial NCT03304184?
The interventions under investigation include: Biodentine (DEVICE), Photac-fil (DEVICE).
Who is sponsoring clinical trial NCT03304184?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03304184's enrollment target sits among peer trials
24 1943rd of 2000 higher than 49 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI